The Ultomiris Pregnancy Registry Study

Are you pregnant or were you previously pregnant? Do you have an autoimmune disease, and were you prescribed ULTOMIRIS® to help treat it? If so, you may be able to take part in a pregnancy registry study. All eligible women will have taken ULTOMIRIS, before realizing they were pregnant, during pregnancy, or breastfeeding.

ULTOMIRIS is a prescription medicine used to treat rare conditions affecting the immune system, such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). There are no available data on ULTOMIRIS use in pregnant women. If you are pregnant or breastfeeding, you should consult your healthcare provider before taking ULTOMIRIS.

HCP Login Patient

How do I participate?

Fill out the contact form to have a study representative contact you with more information about this pregnancy registry study

Call the registry study’s toll-free number
+1-833-793-0563 and speak to a study representative

Ask your healthcare provider to help you complete the contact form